| http://www.w3.org/ns/prov#value | - CSL Behring awarded advocacy grants worth around $100,000 to six patient groups through its Local Empowerment for Advocacy Development program, which supports groups helping patients using plasma-derived or recombinant therapies for rare and serious diseases, including bleeding disorders, immune deficiencies and hereditary angioedema.
|
